Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial
Published Online: 2022-10-?
Journal: The Lancet Respiratory Medicine•Publisher: Elsevier BV
Authors: Abdel G. Babiker•Adit A. Ginde•Adriana Sánchez•Ahmad Mourad•Akram Khan•Alison Templeton•Amy C. Weintrob•Andrew N. Phillips•Andrew Vekstein•Angela J. Rogers•Annetine C. Gelijns•B. Taylor Thompson•Barbara Trautner•Barbine Tchamba Agbor Agbor•Barnaby E. Young•Beatrice Jones•Birgit Grund•Bradley G. Leshnower•Cavan S. Reilly•Christina C. Chang•D. Clark Files•D. Shane O'Mahony•Daniel D. Murray•David J. Douin•David Sahner•Eduardo Fernández-Cruz•Eleftherios Mylonakis•Elizabeth S. Higgs•Evan P. Cassity•Eyad Almasri•Fadi Shehadeh•Fleur Hudson•Francis Kiweewa•Gail Matthews•Garyfallia Poulakou•Gemma Lladós•Giota Touloumi•Greg Grandits•H. Clifford Lane•Hassan S. Taha•Huldrych F. Günthard•Ivan Kimuli•J. Scott Overcash•James D. Neaton•Jay S. Steingrub•Jens D. Lundgren•Jens-Ulrik Jensen•Jonathan D. Casey•Jose Luis Morales-Rull•Joseph K. Lutaakome•Kami Kim•Katherine L. Boyle•Kathryn A. Hibbert•Katy Shaw-Saliba•Kirk U. Knowlton•Konstantinos N. Syrigos•Lavannya M. Pandit•Leire Balerdi-Sarasola•Lindsay Leither•Lourdes Mateu•M. Tauseef Rehman•Mamta K. Jain•Marc Teitelbaum•Maria L. Padilla•Marisa Di Natale•Mark T. Esser•Mezgebe Berhe•Michael A. Matthay•Michael R. Filbin•Michael Waters•Moses Kibirige•Nicole Engen•Noel Ivey•Pedro Garbes•Peter Chen•Peter E. Morris•Prasad Manian•R. Duncan Hite•Ralph Rogers•Robert C. Hyzy•Robert Kidega•Robert L. Gottlieb•Robin L. Dewar•Roger Paredes•Rubria Marines-Price•Samuel M. Brown•Sanjay R. Bhagani•Sarah Pett•Sergio España-Cueto•Shweta Sharma•Srikant Ramachandruni•Thanh Tran•Thomas A. Murray•Thomas L. Holland•Timothy Hatlen•Tomas O. Jensen•Uriel Sandkovsky•Ven Natarajan•Victoria J. Davey•Vidya Menon•Virginia Kan•Wesley H. Self•Wonder Drake